Evidence map›Paper›PMID 35089321›Full record

ArticleThe British journal of surgery2022

Wire- and magnetic-seed-guided localization of impalpable breast lesions: iBRA-NET localisation study.

Rajiv V Dave, Emma Barrett, Jenna Morgan, Mihir Chandarana, Suzanne Elgammal, Nicola Barnes, Amtul Sami, Tahir Masudi, Sue Down, Chris Holcombe and 7 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in The British journal of surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 14 institutions in 1 country.

Rajiv V DaveThe Nightingale Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.ORCID 0000-0001-6827-8090
Emma BarrettDepartment of Medical Statistics, Manchester University Hospitals NHS Foundation Trust, Wythenshawe Hospital, Manchester, UK.
Jenna MorganDepartment of Oncology and Metabolism, University of Sheffield Medical School, Sheffield, UK.ORCID 0000-0002-5337-5581
Mihir ChandaranaBreast Unit, Lincoln County Hospital, United Lincolnshire Hospitals NHS Trust, Lincoln, UK.ORCID 0000-0002-9219-0184
Suzanne ElgammalBreast Unit, University Hospital Crosshouse, NHS Ayrshire and Arran, Kilmarnock, UK.
Nicola BarnesThe Nightingale Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Amtul SamiBreast Unit, Lincoln County Hospital, United Lincolnshire Hospitals NHS Trust, Lincoln, UK.
Tahir MasudiBreast screening and assessment unit, Rotherham General Hospital, Rotherham NHS Foundation Trust, Rotherham, UK.
Sue DownBreast Unit, James Paget University Hospital, Great Yarmouth, UK.
Chris HolcombeBreast Unit, Liverpool University Hospitals Foundation Trust, Liverpool, UK.
Shelley PotterNational Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.ORCID 0000-0002-6977-312X
Santosh K SomasundaramBreast Screening Unit, Royal Lancaster Infirmary, Lancaster, UK.
Matthew GardinerDepartment of Plastic Surgery, Frimley Health NHS Foundation Trust, Slough, UK.ORCID 0000-0002-8058-4186
Senthurun MylvaganamHealth Education West Midlands, Royal Wolverhampton NHS Trust, Wolverhampton, UK.
Anthony MaxwellThe Nightingale Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
James HarveyThe Nightingale Breast Cancer Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
iBRA-NET Localisation Study collaborative
University of Manchester · GBRoyal Lancaster Infirmary · GBLincoln County Hospital · GBManchester Academic Health Science Centre · GBManchester University NHS Foundation Trust · GBNHS Ayrshire and Arran · GBThe Royal Wolverhampton NHS Trust · GBFrimley Health NHS Foundation Trust · GBJames Paget University Hospital · GBNorth Bristol NHS Trust · GBRotherham General Hospital · GBUniversity of Liverpool · GBUniversity of Sheffield · GBWythenshawe Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWire localization is historically the most common method for guiding excision of non-palpable breast lesions, but there are limitations to the technique. Newer technologies such as magnetic seeds may allow some of these challenges to be overcome. The aim was to compare safety and effectiveness of wire and magnetic seed localization techniques.

methodsWomen undergoing standard wire or magnetic seed localization for non-palpable lesions between August 2018 and August 2020 were recruited prospectively to this IDEAL stage 2a/2b platform cohort study. The primary outcome was effectiveness defined as accurate localization and removal of the index lesion. Secondary endpoints included safety, specimen weight and reoperation rate for positive margins.

resultsData were accrued from 2300 patients in 35 units; 2116 having unifocal, unilateral breast lesion localization. Identification of the index lesion in magnetic-seed-guided (946 patients) and wire-guided excisions (1170 patients) was 99.8 versus 99.1 per cent (P = 0.048). There was no difference in overall complication rate. For a subset of patients having a single lumpectomy only for lesions less than 50 mm (1746 patients), there was no difference in median closest margin (2 mm versus 2 mm, P = 0.342), re-excision rate (12 versus 13 per cent, P = 0.574) and specimen weight in relation to lesion size (0.15 g/mm2versus 0.138 g/mm2, P = 0.453).

conclusionMagnetic seed localization demonstrated similar safety and effectiveness to those of wire localization. This study has established a robust platform for the comparative evaluation of new localization devices.

Indexed as

MagnetsAgedBreast NeoplasmsFemaleFiducial MarkersHumansMargins of ExcisionMastectomy, SegmentalMiddle AgedNeoplasm StagingPostoperative ComplicationsProspective Studies

Identifiers

PMID35089321
PMCPMC10364683
OpenAlexW4205193763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.